Drug Shortage Report for ISOPTIN SR
Report ID | 81791 |
Drug Identification Number | 00742554 |
Brand name | ISOPTIN SR |
Common or Proper name | VERAPAMIL HYDROCHLORIDE |
Company Name | BGP PHARMA ULC |
Market Status | DORMANT |
Active Ingredient(s) | VERAPAMIL HYDROCHLORIDE |
Strength(s) | 240MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100 BT |
ATC code | C08DA |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-04-16 |
Estimated end date | 2019-06-28 |
Actual end date | 2019-06-25 |
Shortage status | Resolved |
Updated date | 2019-06-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2019-06-26 | English | Compare |
v7 | 2019-06-25 | French | Compare |
v6 | 2019-06-25 | English | Compare |
v5 | 2019-06-18 | French | Compare |
v4 | 2019-06-18 | English | Compare |
v3 | 2019-04-17 | English | Compare |
v2 | 2019-04-16 | French | Compare |
v1 | 2019-04-16 | English | Compare |
Showing 1 to 8 of 8